High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
about
From oligonucleotide shapes to genomic SELEX: novel biological regulatory loopsThe neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementiaAptamers and the RNA world, past and presentFit for the Eye: Aptamers in Ocular DisordersSelection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor.RNA and DNA aptamers as potential tools to prevent cell adhesion in disease.High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozymeDevelopment of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition.Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template.Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selectionNucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsCell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.High affinity ligands from in vitro selection: complex targets.Enrichment for RNA molecules that bind a Diels-Alder transition state analog.Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.Reflections of a Darwinian Engineer.Aptamers as targeted therapeutics: current potential and challenges.In vitro selection of RNA aptamers to a protein target by filter immobilization.Nucleic acid aptamers in cancer research, diagnosis and therapy.Beyond antibodies: new affinity reagents to unlock the proteome.In vitro selection of RNA molecules that inhibit the activity of ricin A-chain.In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain proteinAlignment editing and identification of consensus secondary structures for nucleic acid sequences: interactive use of dot matrix representations.High-affinity RNA ligands to human alpha-thrombin.Modified RNA sequence pools for in vitro selection.Oligonucleotides as research, diagnostic, and therapeutic agents.RNA molecules that bind to and inhibit the active site of a tyrosine phosphatase.Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix.An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.A geometrical approach in folding a pseudoknot motif within the E. coli 16S-RNA.New Horizons with A Multi Dimensional Tool for Applications in Analytical Chemistry—Aptamer
P2860
Q24671006-00660458-E4CF-474C-B249-EFECD5B8F0A4Q28513858-397415C4-A2DA-455A-B108-E757A08CBFCDQ28731938-5F1308A7-D16F-4A9D-B905-2D76B1D39327Q28828283-35BDF93B-CB7A-4CFF-B0AD-A8ABB0946254Q30463953-22F1A208-9AB4-4909-81B1-EE76C1237600Q30659888-2F184E02-21FC-4973-8C5E-C4D71373AEC3Q30778211-B952F455-A511-406D-82AF-0066C4B3DC1AQ33492343-021F4127-DDBD-485B-8535-5DF25909638BQ33752349-8067C1A8-F487-4C4B-AC38-FAE10D6F2032Q34276825-60674EE8-AAD9-4BA6-9707-85330C6FF597Q34409758-12BE1637-BEB6-4FE7-919C-A433A471A886Q35309726-1B0E8207-B50D-46E6-BA59-CAF6751C22B7Q35693567-004AE969-AC42-4111-9DDB-137D18E0C8E2Q35974349-EFBFB9B0-8DB7-42CF-A832-42CEAADCA763Q36018956-2D2CB563-FD40-4C27-A19B-5E19C8A5B23FQ36367219-ADF13E73-1FCC-489F-A7AB-8FB354ED2176Q36729048-18CA14D7-ECAE-42EC-8A22-67D9B9E640B2Q36820144-08F4BDE0-80CC-47A4-86F2-F149F8796D89Q37600648-5E696AF7-7EBC-4638-8C49-CCE1C5D03E9AQ38290290-6D363F96-5F01-482C-91E3-467F01E099CAQ38291588-4592E7EB-2A59-472E-AB32-3C8C4FAD1395Q38308357-D027ADFB-29BE-42C1-BD9D-0F835AD3D971Q38309923-FA831A0A-0519-4ABF-8A5F-86572F270D9DQ38315511-142E46AD-0D08-4376-9D16-4CD712B267ACQ39575228-70A0D34C-B1DC-4D2A-981C-8099EEBDCF61Q40396603-048BE301-350E-4524-B31D-DC4FD46134DDQ40400495-0CD8F6D6-4B8B-4F03-91CF-611F85E9C5C4Q40523091-60D53095-A2B1-4180-985F-E186A07F8E57Q40541574-B067A360-1639-4AAB-A338-322E1A0E9EF5Q41485824-99C9EE27-CBE2-4661-9C20-DC957A387368Q42830076-AC143E7D-FF8D-4876-A836-586B07E020D3Q46713995-44073D7D-5E4F-4D43-9499-B242050A6EBDQ52295172-D0CFF49A-2DA3-4BE1-BAEF-64AA82838E70Q58129411-7D65F5E2-0190-47B0-8984-12C3C23C3EB4
P2860
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@ast
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@en
type
label
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@ast
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@en
prefLabel
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@ast
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@en
P2093
P2860
P356
P1476
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
@en
P2093
P2860
P304
11227-11231
P356
10.1073/PNAS.90.23.11227
P407
P577
1993-12-01T00:00:00Z